Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.32%
SPX
-0.01%
IXIC
+0.05%
FTSE
+0.22%
N225
-0.21%
AXJO
+1.37%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest Alkermes plc News

benzinga.com

Expert Outlook: Alkermes Through The Eyes Of 6 Analysts

5 days ago
cnbc.com

Here are Tuesday's biggest analyst calls: Nvidia, Microsoft, Tesla, Netflix, Meta, SolarEdge & more

Feature Image for interests on Basic Materials, Breaking News: Investing, Breaking News: Markets, Consumer Cyclical from cnbc.com
5 days ago
benzinga.com

Alkermes Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)

about 1 month ago
finance.yahoo.com

Is Alkermes (ALKS) The Most Undervalued Quality Stock To Buy According To Analysts?

Feature Image for interests on Alkermes, ETF, Financial Services, Global Investment Strategist from finance.yahoo.com
9 months ago
businesswire.com

JAGGAER Celebrates Customer Success with Two Wins at SIG’s 2024 Future of Sourcing Awards Ceremony

Feature Image for interests on Healthcare, Stock from businesswire.com
9 months ago
finance.yahoo.com

AstronauTx appoints Jane Rhodes as Chief Executive Officer and Expands Executive Team

Feature Image for interests on Alzheimer'S Disease, Amyotrophic Lateral Sclerosis, Astronautx Ltd, Biotechnology Company from finance.yahoo.com
10 months ago
finance.yahoo.com

Alkermes to Host Investor Event to Review Orexin Portfolio Strategy

Feature Image for interests on Alkermes, Healthcare, Investor Relations, Stock from finance.yahoo.com
10 months ago
finance.yahoo.com

Alkermes to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Conference

Feature Image for interests on Alkermes, Financial Services, Healthcare, Novel Mechanisms from finance.yahoo.com
10 months ago
finance.yahoo.com

Alkermes launches Phase II trial of ALKS 2680 for narcolepsy type 2

Feature Image for interests on Alkermes, Healthcare, Narcolepsy, Phase Ii from finance.yahoo.com
11 months ago
finance.yahoo.com

We Ran A Stock Scan For Earnings Growth And Alkermes (NASDAQ:ALKS) Passed With Ease

Feature Image for interests on Alkermes, Earnings Growth, Earnings Per Share, Healthcare from finance.yahoo.com
11 months ago

Latest Cashu News

publisher logo
Cashu

Alkermes plc: Diverse Analyst Perspectives on Growth and Challenges in Neuropsych Development

3 days ago
publisher logo
Cashu

Alkermes plc: Mixed Analyst Views on Biotech Potential and Market Challenges

5 days ago
publisher logo
Cashu

Alkermes plc: Analysts’ Mixed Views on Future Prospects in a Complex Pharma Landscape

about 1 month ago
Stocks
Health Care
alks
Alkermes plc
ALKS
-0.14 (-0.49%)
29.215
USD
At close at Jul 18, 20:38 UTC
Summary
News
Signals
Benchmarks
Financials